Kenya stopped active surveillance in 2023, but the disease is still causing hospitalisation and deaths of old people ...
MRNA-1283 is under clinical development by Moderna and currently in Phase III for Coronavirus Disease 2019 (COVID-19).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback